Novo Nordisk sues competitor Eli Lilly over misleading advertising

Danish pharmaceutical company Novo Nordisk has filed a lawsuit in the United States against its competitor Eli Lilly. The company alleges that Eli Lilly's advertisements for the weight-loss injection Zepbound and the diabetes medication Mounjaro are misleading.




